Chronic Fatigue Syndrome (CFS) in 15 dogs and cats with specific biochemical and microbiological anomalies.

A great deal of controversy and speculation surrounds the etiology of Chronic Fatigue Syndrome (CFS) in human patients and the existence of a similar illness in animals. To evaluate the association with a presumptive staphylococcal infection and bacteremia, seven dogs and eight cats diagnosed with CFS (two meeting the CDC working case definition) were submitted to rapid blood cultures and fresh blood smears investigations. Nine out of 15 blood cultures proved Staph-positive and four isolates were specified as S. xilosus (3) and S. intermedius (1). The presence of micrococci-like organisms in the blood was of common observation among these subjects, in association with fatigue/pain-related symptoms and biochemical abnormalities suggestive of a myopathy. Following treatment with a low dosage arsenical drug (thiacetarsamide sodium, Caparsolate, i.v., 0.1 ml/kg/day) all patients experienced complete remission. Micrococci disappeared from the blood at post-treatment controls made 10-30 days later. The outcomes were compared with those of five healthy controls and five 'sick with other illness' patients showing significant difference.     

Immunological findings in 3 dogs clinically diagnosed with allergic rhinitis

Three dogs clinically diagnosed with allergic rhinitis (AR) were examined for their immunological findings. House dust mites (HDM) such as Dermatophagoides farinae (DF) and D. pteronyssinus (DP) were identified as positive allergens in the 3 dogs with both intradermal skin test and serum antigen-specific IgE test. Lymphocyte blastogenic response of peripheral blood mononuclear cells (PBMCs) under stimulation with DF antigen in dogs with AR was higher than that in 4 healthy control dogs. Expression level of IL-4 mRNA in PBMCs obtained from the 3 AR dogs was higher than that in PBMCs obtained from 4 healthy control dogs before and after stimulation with DF antigen. Expression level of IFN-gamma mRNA in PBMCs was not different between the AR and control dogs before and after stimulation with DF antigen. These results suggested that allergic reaction to HDM antigen and T(H)2-type immune response were associated with the development of AR in 3 dogs examined in this study.     

Horner's syndrome in dogs and cats: 100 cases (1975-1985)

The medical records of 74 dogs and 26 cats with Horner's syndrome (HS) that were admitted to the New York State College of Veterinary Medicine between January 1975 and October 1985 were reviewed. In dogs, but not cats, HS was associated significantly (P less than 0.01) with increasing age. Dogs with hypothyroidism (defined liberally but not rigorously), intracranial neoplasia, or thoracic neoplasia, cats with otitis media/interna (defined liberally), and dogs and cats with brachial plexus root avulsion were at greater risk for developing HS than were animals that were hit by a car. Dogs and cats with otitis externa were at less risk of developing HS than were animals that were hit by a car. The cause of HS could not be determined in 50% of dogs and 42.3% of cats. The results of topical adrenergic drug testing in dogs were inconclusive in localizing lesion site. In dogs and cats, HS appeared to be unassociated with gender, breed, or right vs left side. The important causes of HS in dogs and cats were trauma (hit by car), brachial plexus root avulsion, intracranial and thoracic neoplasia, and otitis media/interna.     

Horner's syndrome in dogs and cats: 49 cases (1980-1986)

Medical records of 49 dogs and cats with Horner's syndrome were reviewed. Causes included head, neck, and chest trauma, chronic otitis, cranial thoracic mass, and injury attributable to cleaning of the external ear canal. Cause could not be delineated in 54.5% of the dogs. Numerous diagnostic tests and pharmacologic challenge exposure with epinephrine were used to localize the site of injury. Resolution of all clinical signs was observed in 36 animals and required a mean of 7.7 weeks.     

Locked jaw syndrome in dogs and cats: 37 cases (1998-2005)

A consecutive series of cases of dogs and cats with locked jaw syndrome (inability to open or close the mouth) are reported in this study. Dogs were significantly overrepresented (84.0%) and adult dogs were more frequently affected (81.0%). Temporomandibular joint ankylosis due to fracture was the most common cause (54.0%) of locked jaw syndrome. Additional potential causes of locked jaw syndrome are masticatory muscle myositis, neoplasia, trigeminal nerve paralysis and central neurological lesions, temporomandibular joint luxation and dysplasia, osteoarthritis, retrobulbar abscess, tetanus, and severe ear disease. Treatment of locked jaw is directed towards the primary cause. It is important to treat the tonic spasm in order to minimize periarticular fibrosis. Surgical intervention is recommended for temporomandibular joint ankylosis. Masticatory muscle myositis treatment is initiated by gradually opening the mouth, with medical treatment based on immunosuppressive therapy. Fracture and masticatory muscle myositis are associated with a relatively good prognosis in regard to short-term outcome as compared to animals with central neurologic lesions or osteosarcoma which have a poor prognosis.     

Chronic fatigue syndrome (CFS) associated with Staphylococcus spp. bacteremia, responsive to potassium arsenite 0.5% in a veterinary surgeon and his coworking wife, handling with CFS animal cases

Chronic fatigue syndrome (CFS) in human patients remain a controversial and perplexing condition with emerging zoonotic aspects. Recent advances in human medicine seem to indicate a bacterial etiology and the condition has already been described in horses, dogs, cats and birds of prey in association with micrococci-like organisms in the blood. To evaluate the possibility of a chronic bacteremia, a veterinary surgeon (the author) and his coworking wife, both diagnosed with CFS and meeting the CDC working case definition, were submitted to rapid blood cultures and fresh blood smears investigations. Blood cultures proved Staph-positive and micrococci-like organisms in the blood were repeatedly observed in the 3-year period preceding the arsenical therapy, during which several medicaments, including antibiotics, proved unsuccessful. Following treatment with a low dosage arsenical drug (potassium arsenite 0.5%, im., 1 ml/12 h, for 10 days) both patients experienced complete remission. At the post-treatment control made 1 month later, micrococci had disappeared from the blood, and the CD4/CD8 ratio was raising.

Résumé

L'étiologie du Syndrome de Fatigue Chronique (SDF) chez l'homme reste entourée de nombreuses spéculations et perplexités. Apparemment il s'agit d'une zoonose émergente qui a déjà été décrite chez les chevaux, les chiens, les chats et les oiseaux de proie, associée à la présence de bactéries types micrococciques trouvées dans le sang. Récente publications humaines semblent indiquer une étiologie bactériologique. Afin d'évaluer la possible association avec une infection chronique à bactéries, un vétérinaire practicien (l'auteur) e sa femme, avec un diagnostic de CFS et correspondant à la définition humaine pour cette maladie, on été soumis à hémocultures et à la recherche microscopique directe de germes dans le sang. Le hémocultures furent positives pour Staphylococcus spp. Chez les deux suject examinés, des bactéries type micrococciques ont été maintes fois retrouvées sur le globules rouges pendant les trois ans qui on précédé la thérapie arsenicale, et leur présence était associée aux symptomes de fatigue/douleur et à des anomalies biochimiques correspondantes. Au cours de la meme periode l'utilisations d'autre médicaments, y inclus des antibiotiques, n'avait sorti aucun résultat thérapheutique. En revanche, les symptômes ont disparu après traitement par l'arsenite de potassium à 0,5% (liqueur de fowler 1 ml/12 h pendant 10 jours). Cette thérapeutique a permis une guérison complète et durable du syndrome chez les deux sujets et l'augmentation du rapport CD4/CD8.     

Horner's syndrome in cats and dogs: a review

The literature was reviewed and reference made to a retrospective study of cases of Horner's syndrome seen at the Royal (Dick) School of Veterinary Studies. It was concluded that the cardinal diagnostic sign of Horner's syndrome is miosis. Ptosis, prolapse of the third eyelid and apparent enophthalmos are frequently presented but other signs of sympathetic deficit such as facial or aural vasodilatation are observed less consistently. The clinical diagnosis may be confirmed by pupillary response to cocaine. Horner's syndrome was frequently associated with trauma and less commonly with neoplasia. In a significant number of cases the cause was undetermined. Lesions of central neurons are reported infrequently while lesions of preganglionic and postganglionic neurons are described more often and appear to have a similar incidence. Preganglionic lesions most frequently involve the thoracic spinal cord and cervical sympathetic trunk while postganglionic lesions usually result from middle ear and retrobulbar disorders. The site of the lesion may be determined on the basis of clinical signs and pupillary response to phenyladrenalin or hydroxyamphetamine which both distinguish postganglionic lesions from preganglionic and central lesions.     

Primary immune-mediated thrombocytopenia in 30 dogs (1997-2003)

During a 6-year period, primary (idiopathic) immune-mediated thrombocytopenia was retrospectively evaluated in 30 dogs. Ages of the dogs ranged from 3 months to 10 years (median 4 years); female dogs were markedly overrepresented with 73%. Clinical examination revealed hemorrhages in 70% of the dogs. Platelet counts ranged from 0 to 111,000/microL (median 8000/microL); 77% of the dogs had platelet counts <30,000/microL. Seventeen dogs were anemic (hematocrit 9% to 36%; median 31%). Immunosuppressive therapy was performed in all but one dog. The recurrence rate of 19 dogs that were followed over an extended period (112 to 1684 days; median 340 days) was 26%. Twenty-nine (97%) dogs survived 14 days after initial presentation, and 27 (93%) dogs survived at least the following 15 to 1684 days (median 220 days).     

Anesthesia in dogs and cats with althesin

Tests of the effect of the new steroid anaesthetic alfadion in the drug Althesin are described. Experiments were carried out in three experimental groups. Intramuscular administration of Althesin to dogs at doses 5 to 15 mg. kg-1 does not induce required anaesthesia. After intravenous administration of Althesin to dogs at a dose of 2 mg. kg-1 after diazepam pre-medication at a dose of 0.25 mg.kg-1 i. m., anaesthesia started without excitations immediately after completed application. Anaesthesia lasted on the average 10 minutes and at the time of recovery excitations and side effects occurred. After intravenous administration of Althesin at a dose of 6 mg. kg-1 with diazepam pre-medication 0.25 mg. kg-1 i.m., the course of narcosis in cats was similar to that in dogs, only its duration was on the average 29 minutes.     

Treatment of inflammatory bowel disease (IBD) in dogs and cats

The treatment of inflammatory bowel disease (IBD) possesses numerous difficulties owing to the unclear etiology of the disease. This article overviews the drugs used in the treatment of IBD depending on the intensity of clinical symptoms (Canine Inflammatory Bowel Disease Activity Index and Canine Chronic Enterophaty Clinical Activity Index). Patients demonstrating mild symptoms of the disease are usually placed on an appropriate diet which may be combined with immunomodulative or probiotic treatment. In moderate progression of IBD, 5-aminosalicylic acid (mesalazine or olsalazine) derivatives may be administered. Patients showing severe symptoms of the disease are usually treated with immunosuppressive drugs, antibiotics and elimination diet. Since the immune system plays an important role in the pathogenesis of the disease, the advancements in biological therapy research will contribute to the progress in the treatment of canine and feline IBD in the coming years.     

Nutritional management of chronic renal disease in dogs and cats.

Chronic renal disease is a leading cause of death in dogs and cats. Recent clinical studies show that nutrition plays a key role in improving quality of life and life expectancy of these patients. Typical nutritional interventions include modifying the protein, phosphorus, and lipid concentrations. Nutritional therapy, however, does not simply mean changing the diet; consideration must also be given to ensuring adequate caloric intake and to the method of feeding. Monitoring the effects of the dietary therapy is also crucial to ensure that the patients are responding appropriately to the selected nutritional modifications. Nutritional management must be coordinated with medical management for long term successful treatment.     

B-mode and Doppler ultrasound of chronic kidney disease in dogs and cats

Ultrasound is the imaging test of choice for renal evaluation, because it provides information about the position, size, shape, internal architecture and hemodynamics of the kidneys without harming the patient. In chronic kidney disease, the main findings observed in B-mode ultrasound images are increased cortical echogenicity, loss of corticomedullary differentiation, reduced renal volume and irregular renal contour, and when these changes are associated, they are indicative of end-stage renal disease. However, the cause of kidney disease cannot be determined by ultrasonography, but must be confirmed by means of biopsy, although the presence of ultrasonographic changes indicative of the end-stage of the disease may contraindicate this procedure. The Doppler ultrasound test complements the ultrasonic B-mode examination and enables the assessment of renal perfusion based on a calculation of the hemodynamic indices, which are increased in cases of chronic kidney lesions, with higher values ??in the most severe cases. Thus, ultrasound examinations are not only useful in diagnostics but also play an important role in defining the prognosis of patients with chronic kidney disease.     

Coccidia (protozoa : sporozoasida) of cats and dogs IV. Identity and prevalence in dogs

Examination of 481 faecal samples from North Island dogs revealed that 307 (63.8%) contained coccidia. The majority of infected samples contained a single coccidian but in total 4 valid coccidian parasites of dogs were identified. Two further coccidians, accidentally “parasitic” in dogs, were tentatively identified. The identities and prevalences of the valid coccidian parasites were — Isospora canis (4.0%), Isospora ohioensis (9.2%), Hammondia heydorni (2.7%), Sarcocystis spp. (58.8%); and of the accidental coccidian “parasites” — Isospora lacazei (2.1%), Eimeria spp. (9.8%).